Safety of sarilumab in a Japanese population with rheumatoid arthritis by age group: Data from an interim analysis of a postmarketing surveillance studyHideto Kameda, Yoshiya Tanaka, Toshiya Takahashi et al.|Modern Rheumatology|2024Cited by 4